Merz Therapeutics Gmbh

This study tests whether Xeomin injections (a botulinum toxin type A) can prevent episodic migraines in adults. About 990 participants will receive either Xeomin or a placebo injected into head and neck muscles every 12 weeks for about a year. The main goal is to see if Xeomin re…

This study tests if Xeomin injections can prevent chronic migraines in adults. About 780 people will receive either Xeomin or a placebo injected into head and neck muscles every 12 weeks. The main goal is to see if Xeomin reduces the number of migraine days per month over 6 month…